Predator-elicited flight responses in Swiss-Webster mice: An experimental model of panic attacks

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 20, Issue 2, 1996, Pages 185-205

  Griebel, Guy ^a   Blanchard, D Caroline ^b   Blanchard, Robert J ^b  

^a SANOFI   (France)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

animal model; antipredator defense; benzodiazepine receptor ligands; flight; panic; serotonin receptor ligands; serotonin reuptake inhibitors; Swiss Webster mouse

Indexed keywords

5,6 DIHYDRO 5 METHYL 6 OXO 4H IMIDAZO[1,5 A]THIENO[2,3 F][1,4]DIAZEPINE 3 CARBOXYLIC ACID TERT BUTYL ESTER; ALPRAZOLAM; BENZODIAZEPINE RECEPTOR; CHLORDIAZEPOXIDE; FLUMAZENIL; FLUOXETINE; GEPIRONE; IMIPRAMINE; PIRENPERONE; RITANSERIN; RO 19 8022; S 21187; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; DEFENSIVE BEHAVIOR; MOUSE; NONHUMAN; PANIC; REVIEW;

EID: 0029999103     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-5846(95)00305-3     Document Type: Review

References (83)

1. ASHCROFT, G. W., WALKER, L. G. AND LYLE, A. (1993) A psychobiological model for panic: including models for the mechanisms involved in the regulation of mood and anxiety and implications for behavioural and pharmacological therapies. In: Psychopharmacology of Panic, B. E. Leonard, J. Butler, D. O'Rourke and T. J. Fahy (Eds.), pp 131-143, Oxford University Press, Oxford.
2. BEAUDRY, P., FONTAINE, R., CHOUINARD, G. AND ANNABLE, L. (1986) Clonazepam in the treatment of patients with recurrent panic attacks. J. Clin. Psychiatry 47: 83-85.
3. BELZUNG, C., MISSLIN, R. AND VOGEL, E. (1988) The benzodiazepine receptor inverse agonists β-CCM and RO 15-3505 both reverse the anxiolytic effects of ethanol in mice. Life Sci. 42: 1765-1772.
4. BELZUNG, C., MISSLIN, R. AND VOGEL, E. (1990) Anxiogenic effects of a benzodiazepine receptor partial inverse agonist, RO 19-4603, in a light/dark choice situation. Pharmacol. Biochem. Behav. 36: 593-596.
5. BLANCHARD, R. J., TAUKULIS, H. K., RODGERS, R. J., MAGEE, L. K. AND BLANCHARD, D. C. (1993a) Yohimbine potentiates active defensive responses to threatening stimuli in Swiss-Webster mice. Pharmacol. Biochem. Behav. 44: 673-681.
6. BLANCHARD, R. J., YUDKO, E. B., RODGERS, R. J. AND BLANCHARD, D. C. (1993b) Defense system psychopharmacology: An ethological approach to the pharmacology of fear and anxiety. Behav. Brain Res. 53: 155-165.
7. BRADY, K., ZARZAR, M. AND LYDIARD, R. B. (1989) Fluoxetine in panic disorder patients with imipramine-associated weight gain [letter]. J. Clin. Psychopharmacol. 9: 66-67.
8. CASSANO, G. B., TONI, C., PETRACCA, A., DELTITO, J., BENKERT, O., CURTIS, G., HIPPIUS, H., MAIER, W., SHERA, D. AND KLERMAN, G. (1994) Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo. Eur. Neuropsychopharmacol 4: 47-53.
9. CHARNEY, D. S., WOODS, S. W., GOODMAN, W. K., RIFKIN, B., KINCH, M., AIKEN, B., QUADRINO, L. M. AND HENINGER, G. R. (1986) Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone. J. Clin. Psychiatry 47: 580-586.
10. CHARNEY, D. S., WOODS, S. W., GOODMAN, W. K. AND HENINGER, G. R. (1987) Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology 92: 14-24.
11. CHARNEY, D. S., HENINGER, G. R. AND BREIER, A. (1984) Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch. Gen. Psychiatry 41: 751-763.
12. CHIGNON, J. M. AND LEPINE, E. P. (1989) Panic and hypertension associated with a single dose of buspirone. Lancet II: 46-47.
13. CHOUINARD, G., ANNABLE, L., FONTAINE, R. AND SOLYOM, L. (1982) Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study. Psychopharmacology 77: 229-233.
14. DARRAGH, A., LAMBE, R., O'BOYLE, C., KENNY, M. AND BRICK, I. (1983) Absence of central effects in man of the benzodiazepine antagonist Ro 15-1788. Psychopharmacology 80: 192-195.
15. DEAKIN, J. F. W., GUIMARAES, F. S., WANG, F., HELLEWELL, J. AND HENSMAN, R. (1991) 5-HT receptor mechanisms in human anxiety. In: New Concepts in Anxiety, M. Briley and S. E. File (Eds.), pp 74-93, CRC Press, New York.
16. DEAKIN, J. F. W. AND GRAEFF, F. G. (1991) 5-HT and mechanisms of defense. J. Psychopharmacol. 5: 305-315.
17. DEAKIN, J. F. W., WANG, M. AND GUIMARAES, F. S. (1990) Clinical profile of ritanserin. In: Proceedings of the World Federation of Societies of Biological Psychiatry Symposium, Anonymouspp 16-33, Adis International, Chester.
18. DEN BOER, J. A. AND WESTENBERG, H. G. (1990) Serotonin function in panic disorder: A double blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology 102: 85-94.
19. DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, Fourth Edition (1994) American Psychiatric Association, Washington D.C.
20. DUKA, T., ACKENHEIL, M., NODERER, J. AND DOENICKE, A. (1986) Changes in noradrenaline plasma levels and behavioural responses induced by benzodiazepine agonists with the benzodiazepine antagonist Ro 15-1788. Psychopharmacology 90: 351-357.
21. DUKA, T. AND DOROW, R. (1995) Human experimental psychopharmacology of benzodiazepine receptor inverse agonists and antagonists. In: Benzodiazepine receptor inverse agonists, M. Sarter, D. J. Nutt and R. G. Lister (Eds.), pp 243-270, John Wiley & Sons, New York.
22. DUNNER, D. L., ISHIKI, D., AVERY, D. H., WILSON, L. G. AND HYDE, T. S. (1986) Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study. J. Clin. Psychiatry 47: 458-460.
23. FASSIO, M. AND PAOLETTI, C. (1993) La fluoxetina nel disturbo da attacchi di panico: esperienza clinica. / Fluoxetine in panic disorder: A clinical trial. Riv. Psichiatr. 28: 95-99.
24. 1A receptor antagonists: utility as research tools and therapeutic agents. Trends Pharmacol. Sci. 14: 41-48.
25. FONTANA, D. J., CARBARY, T. J. AND COMMISSARIS, R. L. (1989) Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat. Psychopharmacology 98: 157-162.
26. FONTANA, D. J. AND COMMISSARIS, R. L. (1988) Effects of acute and chronic imipramine administration on conflict behavior in the rat: a potential "animal model" for the study of panic disorder? Psychopharmacology 95: 147-150.
27. FRAZER, G. A. AND LAPIERRE, Y. D. (1987) The effect of buspirone on panic disorder: a case report [letter]. J. Clin. Psychopharmacol. 7: 118-119.
28. GENTIL, V., TAVARES, S., GORENSTEIN, C. AND BELLO, C. (1990) Acute reversal of flunitrazepam effects by Ro 15-1788 and Ro 15-3505: Inverse agonism, tolerance, and rebound. Psychopharmacology 100: 54-59.
29. GORMAN, J. M., LIEBOWITZ, M. R., FYER, A. J., GOETZ, D., CAMPEAS, R. B., FYER, M. R., DAVIES, S. O. AND KLEIN, D. F. (1987) An open trial of fluoxetine in the treatment of panic attacks [published erratum appears in J Clin Psychopharmacol 1988 Feb; 8(1):13]. J. Clin. Psychopharmacol. 7: 329-332.
30. GRAEFF, F. G. (1991) Neurotransmitters in the dorsal periaqueductal grey and animal models of panic anxiety. In: New concepts in anxiety, M. Briley and S. E. File (Eds.), pp 288-307, CRC Press, New York.
31. GRIEBEL, G., BLANCHARD, R. J., LEE, J. C., RODGERS, R. J. AND BLANCHARD, D. C. (1994) Attenuation of antipredator defensive behavior in Swiss-Webster mice following acute and chronic treatment with chlordiazepoxide and alprazolam. Soc. Neurosci. Abstr. 20: 811.
32. GRIEBEL, G., BLANCHARD, D. C., AGNES, R. S. AND BLANCHARD, R. J. (1995a) Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic treatment with imipramine and fluoxetine. Psychopharmacology 120: 57-66.
33. GRIEBEL, G., BLANCHARD, D. C., JUNG, A. AND BLANCHARD, R. J. (1995b) A model of "antipredator" defense in Swiss-Webster mice: Effects of benzodiazepine receptor ligands with different intrinsic activities. Behav. Pharmacol. 6: 732-745.
34. 2A antagonist pirenperone. Pharmacol. Biochem. Behav. 51: 235-244.
35. 1A and α-adrenergic binding sites, in an animal model of anxiety and panic disorders: the Mouse Defense Test Battery with Swiss-Webster mice. J. Psychopharmacol. (Submitted).
36. GRIEZ, E., POLS, H. AND LOUSBERG, H. (1988) Serotonin antagonism in panic disorder: an open trial with ritanserin. Acta Psychiatr. Belg. 88: 372-377.
37. 1A antagonist properties of thiochroman derivatives. ACNP 167 (abstract).
38. HENDRIE, C. A. AND NEILL, J. C. (1991) An animal model of panic disorder. J. Psychopharmacol. 6: 125
39. HIGGITT, A. C., LADER, M. H. AND FONAGY, P. (1986) The effects of the benzodiazepine antagonist Ro 15-1788 on psychophysiological performance and subjective measures in normal subjects. Psychopharmacology 89: 395-403.
40. 3 Antagonists and Benzodiazepines, Their Comparative Behavioural Pharmacology, R. J. Rodgers and S. J. Cooper (Eds.), pp 31-58, John Wiley & Sons, Chichester.
41. HUMBLE, M., ASBERG-WISTEDT, A., WISTEDT, B. AND BERTILSSON, L. (1986) A pilot study of ritanserin (a selective serotonin-2 receptor antagonist) in panic disorder and agoraphobia. Clinical and biochemical effects. C. I. N. P. Congress, Puerto Rico 165 (abstract).
42. 3 receptors. Psychopharmacology 97: 489-495.
43. 1C) receptors on periaqueductal gray aversion. Eur. J. Pharmacol. 161: 219-221.
44. 3 receptors. Psychopharmacology 97: 489-495.
45. LAVIE, P. (1987) RO 15-1788 decreases hypnotic effects of sleep deprivation. Life Sci. 41: 227-233.
46. LISTER, R. G. (1988) Interactions of three benzodiazepine receptor inverse agonists with ethanol in a plus-maze test of anxiety. Pharmacol. Biochem. Behav. 30: 701-706.
47. LOUIE, A. K., LEWIS, T. B. AND LANNON, R. A. (1993) Use of low-dose fluoxetine in major depression and panic disorder. J. Clin. Psychiatry 54: 435-438.
48. MARTIN, P. (1993) Effects of anxiolytic and antidepressant drugs in an animal model of panic. In: Anxiety: Neurobiology, Clinic and Therapeutic Perspectives, M. Hamon, H. Ollat and M. H. Thiébot (Eds.), pp 203-204, Les éditions INSERM/John Libbey Eurotext Ltd, Paris.
49. MAVISSAKALIAN, M. R. AND PEREL, J. M. (1994) Dose-response characterization of the antipanic effects of imipramine. Psychopharmacol. Bull. 30: 171-174.
50. MAVISSAKALIAN, M. R., PEREL, J. M. AND DE GROOT, C. (1993) Imipramine treatment of panic disorder with agoraphobia: the second time around. J. Psychiatr. Res 27: 61-68.
51. MOLEWIJK, H. E., VANDERPOEL, A. M., MOS, J., VANDERHEYDEN, J. A. M. AND OLIVER, B. (1995) Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs. Psychopharmacology 117: 32-40.
52. NORMAN, T. R. AND JUDD, F. K. (1989) Panic attacks, buspirone, and serotonin function. Lancet II: 15
53. NUTT, D. AND LAWSON, C. (1992) Panic attacks. A neurochemical overview of models and mechanisms. Br. J. Psychiatry 160: 165-178.
54. NUTT, D. J., GLUE, P., LAWSON, C. AND WILSON, S. (1990) Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder [see comments]. Arch. Gen. Psychiatry 47: 917-925.
55. PECKNOLD, J. C., LUTHE, L., SCOTT FLEURY, M. H. AND JENKINS, S. (1993) Gepirone and the treatment of panic disorder: an open study. J. Clin. Psychopharmacol. 13: 145-149.
56. PEROUTKA, S. J. AND SNYDER, S. H. (1980) Long-term antidepressant treatment decreases spiroperidol labeled serotonin receptor binding. Science. 210: 88-90.
57. POHL, R., BALON, R., YERAGANI, V. K. AND GERSHON, S. (1989) Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone. Psychopathology. 22 (Suppl 1): 60-67.
58. POHL, R., BALON, R., YERAGANI, V. K. AND GERSHON, S. (1989) Serotonergic anxiolytics in the treatment of panic disorder: A controlled study with buspirone. 16th Collegium Internationale Neuro-Psychopharmacologicum Congress Satellite Conference: New Findings with Anxiolytic Drugs (1988, Munich, Federal Republic of Germany). Psychopathology. 22: 60-67.
59. POLLACK, M. H., TESAR, G. E., ROSENBAUM, J. F. AND SPIER, S. A. (1986) Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up. J. Clin. Psychopharmacol. 6: 302-304.
60. POLLACK, M. H. AND ROSENBAUM, J. F. (1988) Benzodiazepines in panic-related disorders. Special Issue: Perspectives on panic-related disorders. J. Anx. Disord. 2: 95-107.
61. RICKELS, K., WEISMAN, K., NORSTAD, N., SINGER, M., STOLTZ, D., BROWN, A. AND DANTON, J. (1982) Buspirone and diazepam in anxiety: a controlled study. J. Clin. Psychiatry 43: 81-86.
62. ROBINSON, D. S., SHROTRIYA, R. C., ALMS, D. R., MESSINA, M. AND ANDARY, J. (1989) Treatment of panic disorder: nonbenzodiazepine anxiolytics, including buspirone. Psychopharmacol. Bull. 25: 21-26.
63. ROSENBERG, R. AND JENSEN, P. N. (1994) Treatment of panic disorder with alprazolam and imipramine: Clinical relevance of DSM III dysthymia. Eur. Psychiatry 9: 27-32.
64. ROTH, W. T., MARGRAF, J., EHLERS, A., HADDAD, J. M., MADDOCK, R. J., AGRAS, W. S. AND TAYLOR, C. B. (1992) Imipramine and alprazolam effects on stress test reactivity in panic disorder. Biol. Psychiatry 31: 35-51.
65. SANGER, D. J. AND COHEN, C. (1995) Fear and anxiety induced by benzodiazepine receptor inverse agonists. In: Benzodiazepine receptor inverse agonists, M. Sarter, D. J. Nutt and R. G. Lister (Eds.), pp 185-212, John Wiley & Sons, New York.
66. SANO, K., SEKINO, H. AND MAYANAGI, Y. (1972) Results of stimulation and destruction of posterior hippocampus in cases with violent, aggressive and restless behaviors. In: Psychosurgery, E. Hitchcoch, L. Laitinen and K. Vaernet (Eds.), pp 57-Thomas, Springfield.
67. SCHNEIER, F. R., LIEBOWITZ, M. R., DAVIES, S. O., FAIRBANKS, J., HOLLANDER, E., CAMPEAS, R. AND KLEIN, D. F. (1990) Fluoxetine in panic disorder. J. Clin. Psychopharmacol. 10: 119-121.
68. SCHOPF, J., LAURIAN, S., LE, P. K. AND GAILLARD, J. M. (1984) Intrinsic activity of the benzodiazepine antagonist Ro 15-1788 in man: an electrophysiological investigation. Pharmacopsychiatry 17: 79-83.
69. SCHWEIZER, E. AND RICKELS, K. (1988) Buspirone in the treatment of panic disorder: a controlled pilot comparison with clorazepate [letter]. J. Clin. Psychopharmacol. 8: 303.
70. SHEEHAN, D. V., COLEMAN, J. H., GREENBLATT, D. J., JONES, K. J., LEVINE, P. H., ORSULAK, P. J., PETERSON, M., SCHILDKRAUT, J. J., UZOGARA, E. AND WATKINS, D. (1984) Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment. J. Clin. Psychopharmacol. 40: 66-75.
71. SHEEHAN, D. V., RAJ, A. B., SHEEHAN, K. H. AND SOTO, S. (1990) Is buspirone effective for panic disorder? J. Clin. Psychopharmacol. 10: 3-11.
72. SHEEHAN, D. V., RAJ, A. B., HARNETT SHEEHAN, K. AND SOTO, S. (1993a) The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: A double-blind placebo-controlled study. Acta Psychiatr. Scand. 88: 1-11.
73. SHEEHAN, D. V., RAJ, B. A., TREHAN, R. R. AND KNAPP, E. L. (1993b) Serotonin in panic disorder and social phobia. Int. Clin. Psychopharmacol. 8 (Suppl 2): 63-77.
74. SHEHI, M. AND PATTERSON, W. M. (1984) Treatment of panic attacks with alprazolam and propranolol. Am. J. Psychiatry 141: 900-901.
75. SOLYOM, L., SOLYOM, C. AND LEDWIDGE, B. (1991) Fluoxetine in panic disorder. Can. J. Psychiatry 36: 378-380.
76. SPIER, S. A., TESAR, G. E., ROSENBAUM, J. F. AND WOODS, S. W. (1986) Treatment of panic disorder and agoraphobia with clonazepam. J. Clin. Psychiatry 47: 238-242.
77. TREIT, D. (1985) Animal models for the study of anti-anxiety agents: a review. Neurosci. Biobehav. Rev. 9: 203-222.
78. WESTENBERG, H. G. AND DEN BOER, J. A. (1989) Serotonin-influencing drugs in the treatment of panic disorder. Psychopathology. 22 (Suppl 1): 68-77.
79. WESTENBERG, H. G. M. AND DEN BOER, J. A. (1993a) Serotonin in anxiety related disorders. In: Serotonin, from cell biology to pharmacology and therapeutics, P. M. Vanhoutte, P. R. Saxena, R. Paoletti, N. Brunello and A. S. Jackson (Eds.), pp 249-254, Kluwer Academic Publishers, Dordrecht.
80. 1A agonist, in the treatment of panic disorder. Clin. Neuropharmacol. 15 (suppl.): 60
81. WESTENBERG, H. G. M. AND DEN BOER, J. A. (1993b) Serotonergic basis of panic disorder. In: Psychopharmacology of panic, pp 91-109, Oxford University Press, Oxford.
82. WILLNER, P., MUSCAT, R. AND PAPP, M. (1992) Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci. Biobehav. Rev. 16: 525-534.
83. WOODS, S. W., NAGY, L. M., KOLESZAR, A. S., KRYSTAL, J. H., HENINGER, G. R. AND CHARNEY, D. S. (1992) Controlled trial of alprazolam supplementation during imipramine treatment of panic disorder. J. Clin. Psychopharmacol. 12: 32-38.